FDA Inspection 714778 — Waintraub, Stanley E. MD

Waintraub, Stanley E. MD — FEI 3008673157

The FDA completed an inspection of Waintraub, Stanley E. MD on Mar 18, 2011 in Hackensack, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 18, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Hackensack, NJ (United States)

Additional details

Clinical Investigator (CI)

Citations

IDCFRDescription
749821 CFR 312.66Unanticipated problems
751721 CFR 312.66Initial and continuing review
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.